Wistar Institute Names Ronny Drapkin, Penn Medicine Cancer Researcher, President & CEO
Wistar Institute Names Ronny Drapkin, Penn Medicine Cancer Researcher, President & CEO PHILADELPHIA.Today
1140 материалов по теме, собраны автоматически из проверенных источников
Wistar Institute Names Ronny Drapkin, Penn Medicine Cancer Researcher, President & CEO PHILADELPHIA.Today
WV cancer advocates head to Washington in support of legislation for clinical trials Williamson Daily News
WV cancer advocates head to Washington in support of legislation for clinical trials Charleston Gazette-Mail
Why Cancer Patients Miss Out on Clinical Trials: The Referral Gap Explained Bioengineer.org
Liver Cancer Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight StreetInsider
Исследование: антидепрессанты могут помогать онкопациентам эффективнее лечиться от рака Нож — Интеллектуальный журнал о культуре и обществе.
Marcolin Renews Commitment to Fondazione AIRC for Cancer Research, Maintains Fellowship VisionMonday.com
NCI Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research Oncodaily
Sylvester Brings Patients, Researchers and Community Partners Together to Break Barriers to Cancer Clinical Trial Participation Oncodaily
Wafik S. El-Deiry։ Great to Have Dr. Karan Sood Join Me at Brown University for Precision Oncology Research Oncodaily
UCLA researcher wins the 2026 Albany Prize for revolutionary cancer therapy discoveries News-Medical
AVBCC Recognizes Iovance Biotherapeutics’ Dr. Fred Vogt with Inaugural Global Cancer Research & Innovation Award The Des Moines Register
AVBCC Recognizes Iovance Biotherapeutics’ Dr. Fred Vogt with Inaugural Global Cancer Research & Innovation Award EIN News
Ulrika Årehed Kågström Speaking About Momentum 2026, Speakers and the Future of Cancer Research Oncodaily